Corrigendum: Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-Like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-03-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.886343/full |
| _version_ | 1819173752048451584 |
|---|---|
| author | Wen-Hsuan Tsai Fung-Chang Sung Fung-Chang Sung Fung-Chang Sung Lu-Ting Chiu Ying-Hsiu Shih Ming-Chieh Tsai Shu-I Wu Shu-I Wu |
| author_facet | Wen-Hsuan Tsai Fung-Chang Sung Fung-Chang Sung Fung-Chang Sung Lu-Ting Chiu Ying-Hsiu Shih Ming-Chieh Tsai Shu-I Wu Shu-I Wu |
| author_sort | Wen-Hsuan Tsai |
| collection | DOAJ |
| first_indexed | 2024-12-22T20:28:04Z |
| format | Article |
| id | doaj.art-9c178e7da843442ca3a4e8c56ae7fdfd |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-12-22T20:28:04Z |
| publishDate | 2022-03-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-9c178e7da843442ca3a4e8c56ae7fdfd2022-12-21T18:13:40ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122022-03-011310.3389/fphar.2022.886343886343Corrigendum: Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-Like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort StudyWen-Hsuan Tsai0Fung-Chang Sung1Fung-Chang Sung2Fung-Chang Sung3Lu-Ting Chiu4Ying-Hsiu Shih5Ming-Chieh Tsai6Shu-I Wu7Shu-I Wu8Division of Endocrinology and Metabolism, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, TaiwanManagement Office for Health Data (DryLab), Clinical Trial Research Center (CTC), China Medical University Hospital, Taipei, TaiwanDepartment of Health Services Administration, China Medical University, College of Public Health, Taichung, TaiwanDepartment of Food Nutrition and Health Biotechnology, Asia University, Taichung, TaiwanManagement Office for Health Data (DryLab), Clinical Trial Research Center (CTC), China Medical University Hospital, Taipei, TaiwanManagement Office for Health Data (DryLab), Clinical Trial Research Center (CTC), China Medical University Hospital, Taipei, TaiwanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, TaiwanDepartment of Medicine, Mackay Medical College, New Taipei City, TaiwanDepartment of Psychiatry, Mackay Memorial Hospital, Taipei, Taiwanhttps://www.frontiersin.org/articles/10.3389/fphar.2022.886343/fullneuroendocrinediabetesglucagon-like peptide-1 receptor agonistdepressionanxiety |
| spellingShingle | Wen-Hsuan Tsai Fung-Chang Sung Fung-Chang Sung Fung-Chang Sung Lu-Ting Chiu Ying-Hsiu Shih Ming-Chieh Tsai Shu-I Wu Shu-I Wu Corrigendum: Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-Like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study Frontiers in Pharmacology neuroendocrine diabetes glucagon-like peptide-1 receptor agonist depression anxiety |
| title | Corrigendum: Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-Like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study |
| title_full | Corrigendum: Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-Like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study |
| title_fullStr | Corrigendum: Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-Like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study |
| title_full_unstemmed | Corrigendum: Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-Like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study |
| title_short | Corrigendum: Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-Like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study |
| title_sort | corrigendum decreased risk of anxiety in diabetic patients receiving glucagon like peptide 1 receptor agonist a nationwide population based cohort study |
| topic | neuroendocrine diabetes glucagon-like peptide-1 receptor agonist depression anxiety |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2022.886343/full |
| work_keys_str_mv | AT wenhsuantsai corrigendumdecreasedriskofanxietyindiabeticpatientsreceivingglucagonlikepeptide1receptoragonistanationwidepopulationbasedcohortstudy AT fungchangsung corrigendumdecreasedriskofanxietyindiabeticpatientsreceivingglucagonlikepeptide1receptoragonistanationwidepopulationbasedcohortstudy AT fungchangsung corrigendumdecreasedriskofanxietyindiabeticpatientsreceivingglucagonlikepeptide1receptoragonistanationwidepopulationbasedcohortstudy AT fungchangsung corrigendumdecreasedriskofanxietyindiabeticpatientsreceivingglucagonlikepeptide1receptoragonistanationwidepopulationbasedcohortstudy AT lutingchiu corrigendumdecreasedriskofanxietyindiabeticpatientsreceivingglucagonlikepeptide1receptoragonistanationwidepopulationbasedcohortstudy AT yinghsiushih corrigendumdecreasedriskofanxietyindiabeticpatientsreceivingglucagonlikepeptide1receptoragonistanationwidepopulationbasedcohortstudy AT mingchiehtsai corrigendumdecreasedriskofanxietyindiabeticpatientsreceivingglucagonlikepeptide1receptoragonistanationwidepopulationbasedcohortstudy AT shuiwu corrigendumdecreasedriskofanxietyindiabeticpatientsreceivingglucagonlikepeptide1receptoragonistanationwidepopulationbasedcohortstudy AT shuiwu corrigendumdecreasedriskofanxietyindiabeticpatientsreceivingglucagonlikepeptide1receptoragonistanationwidepopulationbasedcohortstudy |